New antithrombotic drugs: a revolution in stroke management

  • Alan Bryer
  • Published 2012 in Cardiovascular journal of Africa


Embolism of cardiac origin accounts for 20% of ischaemic strokes. Atrial fibrillation is by far the most common cause of cardioembolic stroke, and anticoagulation is the treatment generally indicated for secondary, and in many cases, primary prevention. 1 The decision to prescribe warfarin is usually based on an accurate assessment of the likely absolute… (More)


Cite this paper

@inproceedings{Bryer2012NewAD, title={New antithrombotic drugs: a revolution in stroke management}, author={Alan Bryer}, booktitle={Cardiovascular journal of Africa}, year={2012} }